Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03873207
Other study ID # STUDY19080348
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date October 1, 2022

Study information

Verified date January 2024
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study goals are to determine if a novel post-surgical foot offloading device can reduce post-operative pain and expedite the return to daily activity following fat grafting. Investigators will perform a prospective, randomized study utilizing PopSole™, a novel fully customizable post-operative shoe insert, to aid in the recovery of patients post-surgical fat graft injections for pain and limited activity due to foot disorders (ie. fat pad atrophy of the forefoot, heel, or for chronic plantar fasciitis). Standard of care fat grafting is often used in plastic surgery for cosmetic or reconstructive reasons. Foot fat grafting, though not considered part of this research trial, is routinely offered in the UPMC Aesthetic Plastic Surgery center as a cosmetic surgery option; however, treatment modality options following the completion of a foot fat grafting procedure to protect the fat grafts and reduce weight bearing on the fresh fat grafts are limited. Current standard of care options including crutches, scooters, bulky post-operative shoes (ie. Darco shoes [Darco Intl. Huntington WV.]), and the addition of padding to insoles or orthotics that attempt to offload the treated area. Most of these devices are flat and provide poor anatomical support, leading to compensatory gait issues which can lead to further problems and pain in the knees, hips, and back. The most common complication with post-operative foot gear is non-compliance: patients do not wear it. The investigators have devised a novel foot offloading device (PopSole™) which will allow for customization of the area where the fat has been injected into the foot, as well as allow for customizable arch support and elevation of the metatarsals. By randomizing patients to recovery with standard methods versus this new device, the investigators are hopeful for earlier patient ambulation and return to work with decreased pain.


Description:

Subjects will complete the following screening research procedures: 1. Baseline reported outcome measures (PROMs) questionnaires and surveys that will take approximately 25 minutes to complete: - Foot and Ankle Ability Measure (FAAM) questionnaire to assess subject ADL and function ability - Mayo Clinical Scoring System questionnaire (MAYO) to assess subject pain, activity and function - American Orthopaedic Foot and Ankle Society questionnaire (AOFAS) to assess subject pain and function - Manchester Foot and Ankle Disability Index to assess subject foot pain/discomfort - Pittsburgh Foot Survey to assess subject pain, activity, life satisfaction/quality of life - Offload Device Survey to assess the ease and comfort of the offload device 2. Foot ultrasounds will be performed to assess and measure baseline thickness of the plantar fascia, forefoot, or heel. 3. 2D Photographs of both feet will be performed for a visual baseline assessment skin and soft tissue thickness. If the clinical fat graft procedure occurs on a day different from the screening visit, the following research activities will be completed at Visit 2 if the subject continues to remain interested and eligible for study participation: 1. Collection of subject's vital signs (Temp, HR, Resp., BP), medication profile, allergies, weight, BMI calculation and adverse event collection and reporting. 2. Medical and surgical history collection review - the Investigator will confirm that the subject's medical status has not changed since last seen and the subject continues to satisfy eligibility criteria for study intervention. 3. Performance of a limited physical and foot exam by PI and /or Co-investigator MD 4. Women of childbearing potential will receive a urine pregnancy dip test with results documented to study chart. 5. Diary cards with instruction to start entry on the diary card 24 hours after the fat grafting surgery to continue through Post-operative Visit 4 (Month 1) and be placed to study chart. The subject will be instructed to document self-assessment of the following events pertaining to the surgical site: Pain, Bruising, Redness of the skin, Itching, Swelling, Bleeding, Other (any concerns/issues not listed). The subject will be instructed to identify on the diary card the location, date and day of each documented event. Unresolved events at Visit 4 will be carried over for documentation to the adverse event log. 6. 2D Photographs of both feet 7. Offload Device Distribution to remain in use at all times during ambulation and activity instruction to stay off of feet as much as possible for 3 days, then limit ambulation to 10 minutes per hour for 4 weeks and no sports, kicking, running or exercise for 4 weeks. Devices will be provided for both feet to maintain symmetry and gait stability between the two feet.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 1, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Aged 18 years or older and able to provide informed consent 2. Subjects scheduled to undergo a standard of care treatment with fat grafting for foot pain due to forefoot or heel fat pad atrophy or chronic plantar fasciitis as defined by heel pain for greater than 6 months and failed non-surgical therapy 3. Willing and able to comply with follow up examinations, including ultrasounds Exclusion Criteria: 1. Concurrent injury to the lower extremity that would effect gait 2. Open foot ulcerations, fractures, or diagnosis of osteomyelitis of the feet 3. Surgical foot intervention in the last 6 months 4. Diagnosis of pregnancy or the intent of the participant to become pregnant during participation in this study 5. Any issue that per the physician's determination would render the patient not appropriate to continue participation in the study (compliance, change in physical status, etc.)

Study Design


Intervention

Device:
PopSole™ offloading device
Offload Device Distribution to remain in use at all times during ambulation and activity instruction to stay off of feet as much as possible for 3 days, then limit ambulation to 10 minutes per hour for 4 weeks and no sports, kicking, running or exercise for 4 weeks. Devices will be provided for both feet to maintain symmetry and gait stability between the two feet.
padded insole
the control arm will be provided with standard padded insole to wear inside footwear

Locations

Country Name City State
United States UPMC Magee Women's Hospital Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Jeffrey A. Gusenoff, MD University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ultrasonography Tissue thickness (skin, soft tissue, and plantar fascia thickness) as assessed by ultrasound at screening
Primary Ultrasonography Tissue thickness (skin, soft tissue, and plantar fascia thickness) as assessed by ultrasound 1 month post-op
Primary Ultrasonography Tissue thickness (skin, soft tissue, and plantar fascia thickness) as assessed by ultrasound 2 months post-op
Primary Ultrasonography Tissue thickness (skin, soft tissue, and plantar fascia thickness) as assessed by ultrasound 6 months post-op
Primary American Orthopedic Foot and Ankle Society questionnaire (AOFAS). This survey assesses gait (no abnormality to severe abnormality), ankle motion restriction (no restriction to severe restriction), difficulty with waling on uneven surfaces (no difficulty to severe difficulty) and alignment (good to poor). There is no overall summation of results at screening
Primary American Orthopedic Foot and Ankle Society questionnaire (AOFAS). This survey assesses gait (no abnormality to severe abnormality), ankle motion restriction (no restriction to severe restriction), difficulty with waling on uneven surfaces (no difficulty to severe difficulty) and alignment (good to poor). There is no overall summation of results 1 month post-op
Primary American Orthopedic Foot and Ankle Society questionnaire (AOFAS). This survey assesses gait (no abnormality to severe abnormality), ankle motion restriction (no restriction to severe restriction), difficulty with waling on uneven surfaces (no difficulty to severe difficulty) and alignment (good to poor). There is no overall summation of results 2 months post-op
Primary American Orthopedic Foot and Ankle Society questionnaire (AOFAS). This survey assesses gait (no abnormality to severe abnormality), ankle motion restriction (no restriction to severe restriction), difficulty with waling on uneven surfaces (no difficulty to severe difficulty) and alignment (good to poor). There is no overall summation of results 6 months post-op
Primary Pittsburgh Foot Survey Pain and function questionnaire measure. Scale for pain ranges from "Very severe" to "Had no pain". Scale for pain interference ranges from " Very much" to "not at all". Scale of functionality ranges from "unable to do" to "without any difficulty" in regards to a range of specified activities. There is no overall summation of results at screening
Primary Pittsburgh Foot Survey Pain and function questionnaire measure. Scale for pain ranges from "Very severe" to "Had no pain". Scale for pain interference ranges from " Very much" to "not at all". Scale of functionality ranges from "unable to do" to "without any difficulty" in regards to a range of specified activities. There is no overall summation of results 1 month post-op
Primary Pittsburgh Foot Survey Pain and function questionnaire measure. Scale for pain ranges from "Very severe" to "Had no pain". Scale for pain interference ranges from " Very much" to "not at all". Scale of functionality ranges from "unable to do" to "without any difficulty" in regards to a range of specified activities. There is no overall summation of results 2 months post-op
Primary Pittsburgh Foot Survey Pain and function questionnaire measure. Scale for pain ranges from "Very severe" to "Had no pain". Scale for pain interference ranges from " Very much" to "not at all". Scale of functionality ranges from "unable to do" to "without any difficulty" in regards to a range of specified activities. There is no overall summation of results 6 months post-op
Primary Manchester Foot and Ankle Disability Index Pain and function questionnaire assessment. Three responses to a variety of pain and specified activities raging from "On most/every day(s)" which is scored as 2 to "none of the time" which is scored as 0. Summation is made on Functional (0-20 with 20 being the lowest functioning), Personal appearance (0-4 with 4 being the worst), pain (0-10 with 10 being the worst), work/leisure (0-100 with 100 being the worst impact on work/leisure). at screening
Primary Manchester Foot and Ankle Disability Index Pain and function questionnaire assessment. Three responses to a variety of pain and specified activities raging from "On most/every day(s)" which is scored as 2 to "none of the time" which is scored as 0. Summation is made on Functional (0-20 with 20 being the lowest functioning), Personal appearance (0-4 with 4 being the worst), pain (0-10 with 10 being the worst), work/leisure (0-100 with 100 being the worst impact on work/leisure). 1 month post-op
Primary Manchester Foot and Ankle Disability Index Pain and function questionnaire assessment. Three responses to a variety of pain and specified activities raging from "On most/every day(s)" which is scored as 2 to "none of the time" which is scored as 0. Summation is made on Functional (0-20 with 20 being the lowest functioning), Personal appearance (0-4 with 4 being the worst), pain (0-10 with 10 being the worst), work/leisure (0-100 with 100 being the worst impact on work/leisure). 2 months post-op
Primary Manchester Foot and Ankle Disability Index Pain and function questionnaire assessment. Three responses to a variety of pain and specified activities raging from "On most/every day(s)" which is scored as 2 to "none of the time" which is scored as 0. Summation is made on Functional (0-20 with 20 being the lowest functioning), Personal appearance (0-4 with 4 being the worst), pain (0-10 with 10 being the worst), work/leisure (0-100 with 100 being the worst impact on work/leisure). 6 months post-op
Primary Mayo Clinical Scoring System questionnaire (MAYO) Pain and function questionnaire. Pain scale from 0 (worst) to 50 (no pain). Activity limitations, orthotic requirements, antalgic gait, neuropathy and plantar heel tenderness are all graded 10 (best) to 10 (worst). Overall summation is excellent (90-100), good (80-89), fair (70-79), poor (<70) at screening
Primary Mayo Clinical Scoring System questionnaire (MAYO) Pain and function questionnaire. Pain scale from 0 (worst) to 50 (no pain). Activity limitations, orthotic requirements, antalgic gait, neuropathy and plantar heel tenderness are all graded 10 (best) to 10 (worst). Overall summation is excellent (90-100), good (80-89), fair (70-79), poor (<70) 1 month post-op
Primary Mayo Clinical Scoring System questionnaire (MAYO) Pain and function questionnaire. Pain scale from 0 (worst) to 50 (no pain). Activity limitations, orthotic requirements, antalgic gait, neuropathy and plantar heel tenderness are all graded 10 (best) to 10 (worst). Overall summation is excellent (90-100), good (80-89), fair (70-79), poor (<70) 2 months post-op
Primary Mayo Clinical Scoring System questionnaire (MAYO) Pain and function questionnaire. Pain scale from 0 (worst) to 50 (no pain). Activity limitations, orthotic requirements, antalgic gait, neuropathy and plantar heel tenderness are all graded 10 (best) to 10 (worst). Overall summation is excellent (90-100), good (80-89), fair (70-79), poor (<70) 6 months post-op
Primary Foot and Ankle Ability Measure (FAAM) questionnaire Mobility and functionality questionnaire. Scale ranges from "Unable to do" to "no difficulty at all" in response to questions on mobility. There is no overall summation of results. at screening
Primary Foot and Ankle Ability Measure (FAAM) questionnaire Mobility and functionality questionnaire. Scale ranges from "Unable to do" to "no difficulty at all" in response to questions on mobility. There is no overall summation of results. 1 month post-op
Primary Foot and Ankle Ability Measure (FAAM) questionnaire Mobility and functionality questionnaire. Scale ranges from "Unable to do" to "no difficulty at all" in response to questions on mobility. There is no overall summation of results. 2 months post-op
Primary Foot and Ankle Ability Measure (FAAM) questionnaire Mobility and functionality questionnaire. Scale ranges from "Unable to do" to "no difficulty at all" in response to questions on mobility. There is no overall summation of results. 6 months post-op
Secondary Offload Device Survey Device satisfaction measure questionnaire. Questions are answered yes/no in all cases except comfort (0-10 with 10 being the most comfortable), ease of use (0-10 with 10 being most easy to use) and how many hours per night a patient needed to wear a night splint (0-8). at screening
Secondary Offload Device Survey Device satisfaction measure questionnaire. Questions are answered yes/no in all cases except comfort (0-10 with 10 being the most comfortable), ease of use (0-10 with 10 being most easy to use) and how many hours per night a patient needed to wear a night splint (0-8). 2 weeks post-op
Secondary Offload Device Survey Device satisfaction measure questionnaire. Questions are answered yes/no in all cases except comfort (0-10 with 10 being the most comfortable), ease of use (0-10 with 10 being most easy to use) and how many hours per night a patient needed to wear a night splint (0-8). 1 month post-op
Secondary Offload Device Survey Device satisfaction measure questionnaire. Questions are answered yes/no in all cases except comfort (0-10 with 10 being the most comfortable), ease of use (0-10 with 10 being most easy to use) and how many hours per night a patient needed to wear a night splint (0-8). 2 months post-op
See also
  Status Clinical Trial Phase
Completed NCT05071365 - Early Access to Virtual Resources for the Self-management of Plantar Fasciitis N/A
Not yet recruiting NCT05479500 - Investigation of the Efficacy of Myofascial Chain Release Techniques on Plantar Fasciitis N/A
Not yet recruiting NCT05479526 - Effect of The Superficial Back Line on the Development of Plantar Fasciitis
Recruiting NCT04423900 - Smart Phone-Based Application for Evaluation and Rehabilitation of HindFoot Pain N/A
Completed NCT04204824 - Ultrasound Treatment in the Management of Plantar Fasciitis N/A
Completed NCT04162262 - Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment N/A
Completed NCT03246087 - Acupuncture for Plantar Fasciosis in the Primary Care Setting N/A
Completed NCT05647291 - Is ESWT Better in Plantar Fasciitis Treatment? N/A
Completed NCT05347264 - Comparative Effects of Gun Massager and Transverse Friction Massage in Patients With Plantar Fasciitis N/A
Not yet recruiting NCT06106958 - Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy N/A
Recruiting NCT04175288 - The Effectiveness of Ultrasound Treatment in the Management of Plantar Fasciitis N/A
Completed NCT03731897 - Evaluation of the Efficacy of Prolotherapy Treatment in Patients With Plantar Fasciitis: a Randomized Double-blind Study N/A
Recruiting NCT05462002 - Intrinsic Foot Muscle Morphology and Function in Runners With and Without Plantar Fasciitis
Completed NCT05207592 - Urdu Version of Foot and Ankle Disability Index: A Reliability and Validity Study
Completed NCT05856019 - Effects of J Stroke Myofascial Release in Patients With Planter Fasciitis N/A
Completed NCT05867888 - Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis N/A
Completed NCT06023836 - Myofascial Pain Syndrome and Plantar Fasciitis Treatment N/A
Completed NCT04967703 - Physiotherapy Protocols in Treating Plantar Fasciitis N/A
Completed NCT05826301 - Neuromodulation vs. Electrolysis in Plantar Fasciitis N/A
Recruiting NCT03231150 - Plantar Fasciitis Randomized Clinical Control Trial N/A